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Introduction: Differentiation of T helper 17 cells is dependent on the expression of transcription retinoid-related
orphan receptor gamma t (RORγt). The purpose of our study is to determine the role of RORγt expression in T cells
on the development of collagen-induced arthritis (CIA).
Methods: CIA was induced in C57BL/6 and T cell-specific RORγt transgenic (RORγt Tg) mice. At day 10 post-1st-
immunization, lymph node (LN) cells were cultured with type II collagen (CII), and the expression levels of various
cytokines and transcription factors on CD4+ T cells were measured. Total cells or CD4+ cells of draining LN were
harvested from each mouse group after CII-immunization and transferred into C57BL/6 mice, and then CIA was
induced in recipient mice. The expression levels of RORγt and other surface antigens, and the production of
cytokines were analyzed in forkhead box P3 (Foxp3)+ regulatory T (Treg) cells. Foxp3+ Treg cells were analyzed for
suppressive activity against proliferation of effector CD4+ T cells. Interlukin (IL)-10 neutralizing antibody was administrated
in the course of CIA.
Results: CIA was significantly suppressed in RORγt Tg mice compared with C57BL/6 mice. RORγt expression and IL-17
production were significantly higher in CII-reactive CD4+ T cells from RORγt Tg mice. Arthritis was significantly attenuated
in C57BL/6 mice recipient of cells from RORγt Tg mice. Most of Foxp3+ Treg cells expressed RORγt, produced IL-10 but
not IL-17, and overexpressed CC chemokine receptor 6 (CCR6) and surface antigens related to the suppressive activity of
Foxp3+ Treg cells in RORγt Tg mice. In vitro suppression assay demonstrated significant augmentation of the suppressive
capacity of Foxp3+ Treg cells in RORγt Tg mice. CIA was exacerbated in both C57BL/6 mice and RORγt Tg mice by the
treatment of anti-IL-10 antibody.
Conclusion: Our results indicated that RORγt overexpression in T cells protected against the development of CIA. The
protective effects were mediated, at least in part, through the anti-inflammatory effects including high production of
IL-10 of RORγt+Foxp3+ Treg cells.Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory dis-
order characterized by autoimmunity, infiltration of acti-
vated inflammatory cells into the joint synovium, synovial
hyperplasia, neoangiogenesis, and progressive destruction
of the cartilage and bone. This disease affects 1 to 2% of
the population worldwide, most commonly middle-aged
women. The etiology of RA is unknown but pro-
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stated.Thus, correction of any cytokine imbalance can probably
control this disease.
T cells form a large proportion of the inflammatory cells
invading the synovial tissue. CD4+ T cells are one of the
T cell subsets involved in the RA pathological process.
Upon antigenic stimulation and cytokine signaling, naïve
CD4+ T cells activate and differentiate into various T
helper (Th) subsets [1]. Classically Th cells are divided
into Th1 and Th2 subsets according to their cytokine pro-
duction pattern. Recently, IL-17-producing Th17 cells
have been identified and this T cell population appears to
play a critical role in the generation of several types of
autoimmune arthritis such as glucose-6-phosphate isom-
erase (GPI)-induced arthritis [2] and collagen-inducedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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ease onset prevents cartilage and bone destruction, leading
to amelioration of the clinical symptoms of the disease in
CIA [4]. Another study identified IL-17 receptor signaling
as a critical pathway in turning acute synovitis into chronic
destructive arthritis [5]. In RA patients, IL-17 is spontan-
eously produced by the rheumatoid synovium [6], and a
high percentage of IL-17-positive CD4+ Tcells in peripheral
blood mononuclear cells have been detected in RA patients
compared with healthy control subjects [7]. Therefore,
Th17 is considered to be related to the development of RA.
Lineage commitment of each Th cell subset from naive
CD4+ T cells is dependent on the expression of specific
transcription factors induced by specific cytokine environ-
ment. Each Th cell-specific transcription factor does not
only regulate the expression of effector molecules like cyto-
kines and chemokines specific for each Th cell subset, but
also negatively regulates the differentiation of other T cell
subsets [8,9].
Differentiation of Th1 and Th2 cells is dependent
on the expression of transcription factor T-box trans-
cription factor (T-bet) [10] and GATA binding protein-
3 (GATA-3) [11], respectively. Similarly, transforming
growth factor-β (TGF-β) and IL-6 induce the expression
of the transcription factor RORγt, which upregulates the
expression of Th-17-specific molecules, IL-17A, IL-17 F,
CC chemokine ligand 20 (CCL20), and chemokine re-
ceptor CCR6 in mice [12-14]. Recent studies highlighted
the importance of Th cell-specific transcription factors
in the development of autoimmune arthritis. For example,
in mice models of autoimmune arthritis, GATA-3 expres-
sion protects against joint inflammation and destruction
by reducing the differentiation of Th17 cells [15]. Fur-
thermore, we reported previously that T-bet expression
regulates the development of autoimmune arthritis by
suppression of antigen reactive Th17 cells differentiation
via interferon (IFN)γ-independent suppression of RORγt
expression [16]. In RA patients, CD4+ T cells overexpress
IL-17 and RORC (encoding RORγt), compared with
healthy control subjects [17]. Thus, more work is needed
to determine whether RORγt expression and dominant
differentiation of Th17 play a role in the development of
autoimmune arthritis.
Recently, Yoh et al. [18] reported that the T cells of
RORγt transgenic (RORγt Tg) mice under the control of
CD2 promoter express high levels of RORγt and exhibit a
dominant Th17 differentiation pattern [18]. In the present
study, CIA was induced in both RORγt Tg mice and
C57BL/6 mice. The results showed significant protection
of RORγt Tg mice against experimentally induced CIA
compared with C57BL/6 mice. Furthermore, although
RORγt expression and IL-17 production in type II colla-
gen (CII)-reactive CD4+ T cells were significantly higher in
RORγt Tg mice, arthritis was significantly attenuated inC57BL/6 mice recipients of cells from immunized RORγt
Tg mice in adoptive transfer of draining lymph node (LN)
cells or recipients of CD4+ cells. Foxp3+ Treg cells overex-
pressed RORγt and CCR6, produced IL-10 but not IL-17,
and preferentially infiltrated into the joints of RORγt Tg
mice, compared with C57BL/6 mice, after the induction of
CIA. In vitro suppression assay demonstrated that the sup-
pressive activity of Foxp3+ Treg cells was significantly aug-
mented in RORγt Tg mice compared with C57BL/6 mice.
CIA was significantly exacerbated in RORγt Tg mice by
the administration of neutralizing antibody of IL-10. Our
results suggest that the inhibition of arthritis in RORγt Tg
mice was mediated by suppressor cell subsets, including
IL-10 producing CCR6+RORγt+Foxp3+ Treg cells.
Methods
Mice
Age- and sex-matched C57BL/6 mice and C57BL/6 CD2-
RORγt Tg mice (age 6 to 10 weeks) were used in our ex-
periments. RORγt Tg mice were prepared by backcrossing
mice on the C57BL/6 background. For the isolation of
Treg cells, RORγt Tg and C57BL/6 mice were crossed with
knockin mice with Foxp3-IRES-green fluorescent protein
(GFP) (C57BL/6-Foxp3GFP and RORγt Tg-Foxp3GFP mice)
provided by B Malissen (Université de la Méditerranée,
Marseille, France). All mice were maintained under spe-
cific pathogen-free conditions. All experiments described
in this report were performed according to the Guide for
the Care and Use of Laboratory Animals at the University
of Tsukuba, and were approved by the Animal Ethics
Review Committee of the University of Tsukuba.
Induction of collagen-induced arthritis
Native chicken CII was obtained from Sigma-Aldrich
(St Louis, MO, USA). CII was dissolved in 0.01 M acetic
acid and emulsified in complete Freund’s adjuvant (CFA).
CFA was prepared by mixing 5 mg heat-killedMycobacter-
ium tuberculosis (H37Ra; Difco Laboratories, Detroit, MI,
USA) and 1 mL incomplete Freund’s adjuvant (Sigma-Al-
drich). Mice were immunized intradermally at the base of
the tail with 200 μg CII in CFA on days 0 and 21. Arthritis
was evaluated visually, and changes in each paw were
scored on a scale of 0 to 3 as follows; 0 = normal, 1 = slight
swelling and/or erythema, 2 = pronounced swelling, 3 =
ankylosis. The score was summed for each limb (max-
imum score = 12). For histological assessment, mice were
sacrificed at day 42 post first CII immunization, and both
hind limbs were removed. After fixation and decalcifica-
tion, the joints were cut into sections and stained with
hematoxylin and eosin. Quantification of histological
changes was carried out by two independent and blinded
observers, and a histological score was assigned to each
joint based on the degree of inflammation and erosion, as
described previously [16,19]. In the experiment of IL-10
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antibody (JES5-16E3; BioLegend, San Diego, CA, USA) or
isotype control antibody (RTK4530; BioLegend) was ad-
ministrated intraperitoneally every 2 days from day 22 to
30 post first CII immunization.
Cell isolation
Inguinal lymph nodes were collected as draining LNs, and
used for the experiments. CD4+ cells in draining LNs and
spleen were isolated by positive selection using a magnetic-
activated cell sorting (MACS) system with anti-CD4 mAb
(Miltenyi Biotec, Bergisch Gladbach, Germany). CXC che-
mokine receptor 5+ (CXCR5) follicular helper T (Tfh) cells
were isolated with Moflo cell sorter (DakoCytomation,
Glostrup, Denmark) from MACS-isolated CD4+ T cells.
For the isolation of Foxp3+ Treg cells and Foxp3− non-Treg
cells, CD4+GFP+ and CD4+GFP− cells were further purified
using a Moflo cell sorter from MACS-isolated CD4+ T cells
in C57BL/6-Foxp3GFP and RORγt Tg-Foxp3GFP mice. The
isolated cells were used for the experiment of adoptive cell
transfer and quantitative reverse transcriptase-polymerase
chain reaction (RT-PCR) (see below).
Adoptive cell transfer experiment
All cells of draining LN and CD4+ cells were harvested
from C57BL/6 mice and RORγt Tg mice at day 10 post first
CII immunization. Cells were resuspended in PBS, and 1 ×
107 cells from the draining LNs or 2 × 106 of CD4+ cells
were injected intravenously into C57BL/6 mice at day 10
post first CII immunization. Recipient mice were immu-
nized with CII in CFA intradermally on day 11 after the cell
transfer. Arthritis was evaluated visually as described above.
Quantitative RT-PCR
Total RNA was prepared from Tfh cells isolated from
draining LNs on day 10 post first CII immunization with
RNeasy Plus Micro (QIAGEN, Venlo, Netherlands) accord-
ing to the instructions provided by the manufacturer. cDNA
was obtained by reverse transcription with a commercially
available kit (TaKaRa Bio, Otsu, Japan). A TaqMan Assay-
on-Demand gene expression product was used for real-
time PCR (Applied Biosystems, Foster City, CA, USA). The
expression levels of IL21and Bcl6 were normalized relative
to the expression of GAPDH. Analysis was performed with
ABI Prism 7500 apparatus (Applied Biosystems).
Cell culture
Draining LN cells were harvested from each mouse at
day 10 post first CII immunization. Single cell suspen-
sion was prepared, and LN cells (4 × 105 cells/well on a
96-well round-bottom plate) were cultured in Roswell
Park Memorial Institute (RPMI) 1640 medium (Sigma-
Aldrich) containing 10% FBS, 100 units/mL of penicillin,
100 μg/mL of streptomycin, and 50 μM 2-mercaptoethanol.The LN cells were cultured in the presence of 100 μg/mL
denatured chicken CII for 72 h and analyzed for CII-
reactive cytokine production. Furthermore, CD4+GFP+
were stimulated with Dynabeads Mouse T-activator CD3/
CD28 (Invitrogen, Carlsbad, CA, USA) (1 bead/cell) in
round-bottomed 96-well dishes for 96 h and the amount
of IL-10 produced by Foxp3+ Treg cells was measured.
Chemotaxis assay
Cell migration was evaluated using a 24-well, 3-μm pore-size
Transwell system (Corning, Lowell, MA, USA). Briefly,
5 × 105 or 2.5 × 105 of CD4+ cells isolated from draining LN
cells were placed on the top of the Transwell, while CCL20
was added to the bottom of the Transwell system with or
without 10 μg/mL of anti-IL-10 mAb or isotype control anti-
body. After 4 h of incubation at 37°C, the number of cells
that migrated into the lower well was counted by flow cy-
tometry. Foxp3 expression in the isolated CD4+ cells was also
analyzed by flow cytometry before and after the migration.
Flow cytometry
For flow cytometry, the cell surface was stained with the
following antibodies specific for mouse proteins: anti-CD4
(RM4-5 or GK1.5), anti-CD3 (145-2C11), anti-programmed
cell death-1 (29 F.1A12), anti-inducible T-cell co-stimulator
(ICOS) (C398.4A), anti-CC chemokine receptor 6 (CCR6)
(29–2 L17), anti-cytotoxic T-lymphocyte-associated protein
4 (CTLA4) (UC10-4B9), anti-glucocorticoid-induced
tumor necrosis factor receptor (GITR) (DTA-1; all from
BioLegend) and anti-CXCR5 CXCR5 (2G8; BD PharMin-
gen, San Diego, CA, USA). For intracellular cytokine stain-
ing, cells were cultured with or without CII for 72 h, and
GolgiStop (BD PharMingen) was added during the last 4 h
of each culture. The cell surface was stained and then
permeabilized with Cytofix/Cytoperm solution (BD Phar-
Mingen). This was followed by intracellular cytokine stain-
ing with anti-IL-17A (TC11-18H10; BD PharMingen),
anti-IFNγ (XMG1.2; BioLegend), and anti-IL-10 anti-
bodies (JES5-16ES; BioLegend). Mouse Regulatory T Cell
Staining Kit (eBioscience, San Diego, CA, USA) was used
to stain the transcription factors with anti-Foxp3 (MF-14;
Biolegend), anti-T-bet (eBio4B10) and anti-RORγt anti-
bodies (AFKJS-9; both from eBioscience). Annexin V (Bio-
Legend) and propidium iodide (PI) (BioLegend) are used
for the detection of apoptotic cells. Data were acquired
on a FACSCalibur flow cytometer (Becton Dickinson,
Mountain View, CA, USA), and analyzed with FlowJo
software (Tree Star, Ashland, OR, USA).
Analysis of cytokine profiles
The supernatants were collected after the cells were cul-
tured with or without CII for 72 h and the levels of IL-17,
IFNγ, and IL-10 were analyzed by ELISA using the Quan-
tikine ELISA kit (R&D Systems, Minneapolis, MN, USA).
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Fifty-six days post first CII immunization, serum was
collected, then diluted 1:4,000 in blocking solution con-
taining 1% bovine serum albumin (Wako Pure Chemical
Industries, Osaka, Japan) in PBS. Collagen-specific total
IgG, IgG1, IgG2a, IgG2b, and IgG3 titers were measured
by coated 10 μg/mL of CII in PBS on 96-well plates
(Nunc Maxisorp; Nalge Nunc International, Roskilde,
Denmark). The optical density was read at 450 nm using
a microplate reader.In vitro suppression assay and Treg culture
Responder cells (CD4+CD25−GFP−) were labelled with
5 μM carboxyfluorescein diacetate succinimidyl ester
(CFSE, Invitrogen), then cultured with or without un-
labeled Treg cells (CD4+GFP+) at the indicated ratio for
96 h in the presence of Dynabeads Mouse T-activator
CD3/CD28 (1 bead/cell) in round-bottomed 96-well
dishes. The proliferation inhibition rate on the responder
was calculated as: (1-(CFSE percentage Treg plus re-




























Figure 1 Significant suppression of collagen-induced arthritis (CIA) in RORγ
(n = 15) were immunized intradermally with chicken type II collagen (CII) e
(A) Incidence of arthritis. (B) Severity of CIA. Data obtained from three inde
pathology was evaluated on decalcified hematoxylin and eosin-stained sec
groups. Data are mean ± standard error of the mean. *P < 0.05, **P < 0.01, vStatistical analysis
Data are expressed at mean ± standard error of the mean
(SEM). Differences between groups were examined for
statistical significance using Student’s t-test. P-values <0.05
were considered significant.Results
Suppression of CIA in RORγt Tg mice
To evaluate the effects of T cell-specific RORγt expression
on the development of arthritis, we compared the se-
verity of CIA in RORγt Tg mice and C57BL/6 mice.
The incidence of arthritis in RORγt Tg mice was markedly
suppressed compared with C57BL/6 mice (Figure 1A).
Similarly, the arthritis score was also markedly lower in
RORγt Tg than C57BL/6 mice (Figure 1B). Histological
analysis of arthritic joints showed widespread infiltration of
inflammatory cells and synovial hypertrophy throughout
joint tissues of C57BL/6 mice, but not those of RORγt Tg
mice (Figure 1C). Furthermore, analysis of joint inflamma-
tion and erosion scores showed significant suppression of
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mulsified with complete Freund’s adjuvant (CFA) on days 0 and 21.
pendent experiments. (C) At day 42 post first CII immunization, joint
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Figure 2 (See legend on next page.)
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Figure 2 Cytokine production and transcription factor expression in antigen reactive CD4+ T cells. At day 10 days post first type II collagen (CII)
immunization, draining lymph node (LN) cells from C57BL/6 mice (n = 3 or 4) and RORγt Tg mice (n = 3 or 4) were cultured with or without
100 μg/mL of denatured CII for 72 h. (A) IL-17 and IFNγ levels in supernatants measured by ELISA. (B) Cells were analyzed by staining for intracellular
IL-17 and IFNγ. Data represent gated CD3+ and CD4+. Bar graphs show percentages of cytokine-positive cells. (C) The expression levels of RORγt and
T-bet were evaluated by intracellular staining. Data represent gated CD3+ and CD4+. In the histograms, the gray shaded area represents data for the
isotype control. Bar graphs show mean fluorescence intensity (MFI) of T-bet and RORγt Tg. (D) IL-10 levels in supernatants measured by ELISA. (E, F)
Cells were analyzed by staining for intracellular IL-17 and IL-10 (E), and propium iodide (PI) and Annexin V (F). Data represent gated CD3+ and CD4+.
Data are representative of two independent experiments with similar results, and are mean ± standard error of the mean. *P < 0.05, **P < 0.01, versus
C57BL/6 mice, Student’s t-test.
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RORγt Tg-expressing T cells suppressed the development
of CIA.Overexpression of RORγt modulates differentiation of
CII-reactive CD4+ T cells
To determine the effects of RORγt overexpression on CII-
reactive cytokine production, we analyzed draining LN cells
harvested at day 10 post first CII immunization. These cells
were stimulated with CII in vitro before measurement of
cytokine levels in supernatants by ELISA. The level of IL-
17 was significantly higher in RORγt Tg mice than in
C57BL/6 mice, whereas that of IFNγ was comparable in
the two groups (Figure 2A). Fluorescence-activated cell
sorting (FACS) analysis of cytokine expression on CD4+ T
cells also showed no significant difference in IFNγ pro-
duction from CII-reactive CD4+ T cells between the two
groups of mice (Figure 2B). The same analysis showed a
significantly higher IL-17 production by CII-reactive CD4+
T cells of RORγt Tg mice compared with C57BL/6 mice
(Figure 2B). We measured the expression of transcription
factors critical for differentiation of each CD4+ T cells sub-
set. The mean fluorescence intensity (MFI) of RORγt in
CII-reactive CD4+ T cells was significantly higher in RORγt
Tg mice than C57BL/6 mice (Figure 2C), but there was no
difference in T-bet expression between C57BL/6 and
RORγt Tg mice (Figure 2C). We also measured IL-10 pro-
duction by CII-reactive CD4+ T cells by ELISA and FACS.
There was no significant difference in the level of IL-10
between the two groups of mice (Figure 2D), and IL-10
production by CII-reactive CD4+ T cells was almost un-
detectable with FACS analysis in both mice (Figure 2E). Fi-
nally, we examined whether overexpression of RORγt in T
cells increases apoptosis in these cells. FACS analysis of
apoptotic cells stained with PI and annexin V showed that
there was no significant difference between the two groups
of mice in the percentage of apoptotic cells in CD4+ T cells
cultured with CII in vitro (Figure 2F). These results indi-
cate that overexpression of RORγt induced higher IL-17
production from CII-reactive CD4+ T cells, but had no ef-
fect on Th1 differentiation and CII-reactive cytokine pro-
duction other than IL-17,Suppression of anti-CII antibody formation
We examined CII-specific IgG production in RORγt Tg
mice, because CII-specific IgG level is known to correl-
ate with the development of CIA [20]. Sera were col-
lected at day 56 post first CII immunization, and the
levels of CII-specific total IgG, IgG1, IgG2a, IgG2b, and
IgG3 were measured by ELISA. Serum CII-specific total
IgG was significantly lower in RORγt Tg mice than
C57BL/6 mice (P <0.05, Figure 3A), but there was no
significant difference in CII-specific IgG1, IgG2a, IgG2b
and IgG3 (Figure 3B).
The next experiment examined whether the expression
of RORγt affected the differentiation and function of T fol-
licular helper (Tfh) cells. For this purpose, we measured
the expression of CXCR5, programmed death-1 (PD-1),
and inducible T-cell co-stimulator (ICOS), a marker of Tfh
cells, by FACS analysis of CD4+ cells in draining LNs, the
expression of B cell lymphoma 6 (Bcl-6), a master tran-
scription factor of Tfh cell differentiation, and the ex-
pression of IL-21 in Tfh cells. The expression of Bcl-6 and
IL-21 were conducted at day 10 post first CII immu-
nization by real-time PCR using CXCR5+CD4+ Tfh cells
from draining LNs sorted by FACS. The FACS analysis
showed significantly higher expression of CXCR5 in CD4+
T cells in RORγt Tg mice than C57BL/6 mice (Figure 3C).
In addition, ICOS+PD-1+ cells in CXCR5+CD4+ cells was
significantly increased in RORγt Tg mice compared with
C57BL/6 mice (Figure 3D). On the other hand, the expres-
sion level of Bcl-6 was significantly lower on CXCR5+CD4+
Tfh cells of RORγt Tg mice than that of C57BL/6 mice,
and the expression levels of IL-21 on CXCR5+CD4+ Tfh
cells also tended to be reduced in RORγt Tg compared
with C57BL/6 mice (Figure 3E), suggesting the possibility
that the differentiation and the function of Tfh cells is sup-
pressed in RORγt Tg mice. These results indicate that sup-
pression of CIA might be related to decreased anti-CII
antibody formation caused by the dysfunction of Tfh cells
in RORγt Tg mice.
Transfer of T cells from RORγt Tg mice suppresses CIA in
immunized C57BL/6 mice
To determine whether the suppressor cells regulate the de-









































































































































Figure 3 (See legend on next page.)
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Figure 3 Suppression of autoantibody formation. (A, B) At day 56 post first type II collagen (CII) immunization, serum samples were collected
from C57BL/6 mice (n = 22) and RORγt Tg mice (n = 21) for measurement of CII-specific total IgG levels (A), and CII-specific IgG1, IgG2a, IgG2b,
and IgG3 (B) by ELISA. Horizontal lines represent the mean values. (C, D) At day 10 post first CII immunization, the expression of CXCR5 (C) and
the expression of inducible T-cell co-stimulator (ICOS) and programmed cell death-1 (PD-1) (D) in draining lymph nodes (LNs) were analyzed by
fluorescence-activated cell sorting (FACS). Data represent gated CD4+ (C) and CXCR5+CD4+ cells (D). Bar graphs show percentages of CXCR5+
cells (C) and ICOS+PD-1+ cells (D). (E) cDNA was obtained from sorted CXCR5+CD4+ T cells isolated from draining LNs on day 10 post first CII
immunization, and expression levels of Bcl-6 and IL-21 were analyzed by real-time PCR. Data are representative of two independent experiments







































Figure 4 Suppression of collagen-induced arthritis (CIA) in mice after
adoptive transfer of cells from RORγt Tg mice. (A) Severity scores of
arthritis. Total draining lymph-node cells were harvested from C57BL/6
mice and RORγt Tg mice at day 10 post first type II collagen (CII)
immunization, and 1 × 107 cells were injected into C57BL/6 mice
intravenously at day 10 post first CII immunization. Recipient mice were
also immunized with CII in complete Freund’s adjuvant (CFA) intradermally
on day 11 after the cell transfer. (B) CD4+ cells were isolated from draining
lymph nodes of C57BL/6 mice and RORγt Tg mice at day 10 post first CII
immunization, and 2 × 106 cells were injected intravenously into C57BL/6
mice at day 10 post first CII immunization, followed by induction of CIA
using the method described for A. Data are representative of two
independent experiments with similar results, and are mean ± standard
error of the mean. *P< 0.05, Student’s t-test.
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adoptively transferred into immunized C57BL/6 mice, fol-
lowed by induction of CIA. Interestingly, arthritis was sig-
nificantly suppressed in mice recipient of cells from RORγt
Tg mice but not those from C57BL/6 mice (Figure 4A). To
identify the effectual cells, only CD4+ cells isolated from
draining LN of C57BL/6 mice or RORγt Tg mice were adop-
tively transferred into immunized C57BL/6 mice. Arthritis
was also suppressed in mice recipient of CD4+ cells isolated
from RORγt Tg mice only, but not from C57BL/6 mice
(Figure 4B). These results suggest that CD4+ T cells inhibit
the development of autoimmune arthritis in RORγt Tg mice.
RORγt overexpression augments the suppressive function
of Foxp3+ Treg cells
Foxp3-expressing CD4+ T cells are known to suppress T
cell-mediated immune reaction [21]. In the next series of ex-
periments, the expression of Foxp3 in CD4+ T cells was in-
vestigated by intracellular staining using LN cells harvested
at day 10 post first CII immunization. Although there was
no significant difference in Foxp3 expression in CD4+ Tcells
between RORγt Tg mice and C57BL/6 mice, higher expres-
sion of RORγt in Foxp3+ Treg cells was noted in RORγt Tg
mice compared with C57BL/6 mice (Figure 5A, B).
To evaluate whether RORγt+ Foxp3+ Treg cells of
RORγt Tg mice retain their stability and suppressive cap-
acity, we analyzed the production of IL-17 and the expres-
sion of molecules known to be related to Foxp3+ Treg cell
function. The FACS analysis of CD4+ T cells stimulated
with CII in vitro showed IL-17 was produced only by
Foxp3− non-Treg cells in RORγt Tg mice (Figure 5C). The
expression of CD25 (Figure 5D), which is associated with
the stability of Foxp3 expression [22], was not significantly
different between C57BL/6 and RORγt Tg mice. Although
there was no difference in the expression of CTLA4, that
of the co-inhibitory molecule, glucocorticoid-induced
tumor necrosis factor receptor (GITR) was significantly
higher in RORγt Tg than C57BL/6 mice (Figure 5E), sug-
gesting that stability and suppressive capacity was not af-
fected with overexpression of RORγt in Foxp3+ Treg cells.
To provide an answer to the question of whether Foxp3
+ cells can suppress effector cell proliferation in vitro, we
compared the ability of isolated CD4+GFP+ cells from
C57BL/6-Foxp3GFP and RORγt-Foxp3GFP reporter mice toinhibit the proliferation of CD4+CD25−GFP− cells from
C57BL/6-Foxp3GFP mice in vitro. Interestingly, the sup-
pressive capacity of CD4+ GFP+ Treg cells was signifi-
cantly enhanced in RORγt Tg Foxp3GFP mice compared
with C57BL/6-Foxp3GFP reporter mice (Figure 5F), and
CD4+GFP+ cells isolated from RORγt Tg Foxp3GFP mice
produced a larger amount of IL-10 than C57BL/6-
Foxp3GFP mice (Figure 5G). These results indicate that
overexpression of RORγt seems to enhance the suppres-
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Figure 5 (See legend on next page.)
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Figure 5 Overexpression of RORγt augments the suppressive capacity of Foxp3+ CD4+ Treg cells. (A) At day 10 post first CII immunization, the
draining lymph-node (LN) cells were harvested from C57BL/6 mice (n = 3 or 4) and RORγt Tg mice (n = 3 or 4) and subjected to flow cytometry.
(B) Percentage of Foxp3+ cells among CD4+ T cells and mean fluorescence intensity (MFI) of RORγt in Foxp3+ CD4+ cells. (C) Cells were analyzed
by staining for intracellular IL-17 and Foxp3. Data represent gated CD4+. (D) Expression of CD25 on gated CD4+Foxp3+ cells. (E) Expression of
surface markers glucocorticoid-induced tumor necrosis factor receptor (GITR) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) on
Foxp3+CD4+ cells. Flow cytometric data (left) and MFI data of C57BL/6 mice and RORγt Tg mice. (F) Carboxyfluorescein diacetate succinimidyl
ester (CFSE)-labeled CD4+CD25−GFP− cells from C57BL/6-Foxp3GFP mice cultured with or without CD4+GFP+ cells from C57BL/6-Foxp3GFP mice or
RORγt Tg-Foxp3GFP mice and stimulated with anti-CD3/28 beads for 72 h. Left, representative data of two independent experiments with three
mice per group; right, percentage of inhibition rate. (G) IL-10 production by CD4+ GFP+ cells of splenocytes stimulated for 72 h with anti-CD3/28
beads from C57BL/6-Foxp3GFP and RORγt Tg-Foxp3GFP mice. Representative data of two independent experiments with similar results, and are
mean ± standard error of the mean values. *P <0.05, **P <0.01 versus C57BL/6 mice, Student’s t-test.
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of Foxp3+ Treg cells
Because CCR6 expression is positively regulated by RORγt
and contributes to the recruitment of cells to the inflamed
joints [14], we analyzed CCR6 expression on CD4+ T cells
after CII immunization. CCR6 expression on CD4+ T cells
was significantly higher in RORγt Tg than C57BL/6 mice
(Figure 6A, P <0.01). Interestingly, the highest expression
of CCR6 was observed in Foxp3+CD4+ Treg cells in
RORγt Tg mice compared with Foxp3+CD4+ Treg cells in
C57BL/6 mice and Foxp3− non-Treg cells in RORγt Tg
mice (Figure 6B).
To determine the chemotactic activity of CD4+ T cells
to CCL20, the in vitro migration assay was performed
using CCR6+ cells. More CD4+ cells migrated in response
to CCL20 in RORγt Tg than C57BL/6 mice (Figure 6C).
The migrating CD4+ T cells of RORγt Tg mice were
enriched for Foxp3+ T cells (Figure 6D). In another in vivo
experiment on mice, CIA was induced in both C57BL/6-
Foxp3GFP and RORγt Tg-Foxp3GFP reporter mice, and the
expression levels of CCR6 and GFP in CD4+ T cells in-
filtrating the joints were analyzed by flow cytometry. Simi-
lar to the results of in vitro migration assay, more CCR6+
GFP+ Treg cells migrated into the joints of RORγt Tg-
Foxp3GFP reporter mice than C57BL/6-Foxp3GFP reporter
mice (Figure 6E). Considered together, these findings sug-
gest that overexpression of RORγt induced CCR6 expres-
sion in Foxp3+ Treg cells and that the latter cells are
enriched in the inflamed joints of RORγt Tg mice.
Neutralization of IL-10 exacerbates CIA in RORγt Tg mice
To clarify whether the suppression of CIA is related to
IL-10, we administrated anti-IL-10 monoclonal antibody
(mAb) to neutralize IL-10 in the course of CIA. The se-
verity of arthritis was significantly exacerbated in both
C57BL/6 mice and RORγt Tg mice administrated with
anti-IL-10 mAb compared with the mice with isotype
control antibody, respectively (Figure 7A). However, sup-
pression of CIA was not completely cancelled in RORγt
Tg mice with the administration of anti-IL-10 mAb, al-
though there was no statistically significant difference
between C57BL/6 mice and RORγt Tg mice treated byanti-IL-10 mAb (Figure 7A). We also examined the ef-
fect of IL-10 neutralization on the chemotactic activity
of CD4+ T cells isolated from draining LNs at day 10
post first CII immunization in vitro. There was no sig-
nificant difference in the migration of CD4+ T cells in
response to CCL20 by the addition of anti-IL-10 mAb in
both two groups of mice (Figure 7B). These data indi-
cated that IL-10 is related to the inhibition of the devel-
opment of CIA in RORγt Tg mice.
Discussion
The transcription factor RORγt is a master regulator of
the differentiation of Th17 cells and expression of Th17
cytokines; IL-17A, IL-17 F, IL-22 and IL-21 [13]. Previ-
ous studies indicate that both IL-17 and Th17 cells seem
to be involved in the pathogenesis of rheumatoid arth-
ritis and animal model of autoimmune arthritis [3-7,17].
We have previously reported that the development of
murine autoimmune arthritis is suppressed by the over-
expression of T-bet, a master regulator of differentiation
of Th1 cells, and suggested that Th17 cells differenti-
ation is inhibited by T-bet through downregulation of
RORγt [16]. To elucidate the effects of RORγt on T cell
function in autoimmune arthritis, we used RORγt Tg
mice under the control of CD2 promoter. In RORγt Tg
mice, most T cells were considered Th17 cells based on
the high expression level of RORγt and production of
high amounts of IL-17, compared to comparable levels
of IFNγ and IL-4 found in WT mice [16]. Contrary to
our expectation, overexpression of RORγt provided pro-
tection against the development of autoimmune arthritis
in mice. While the exact mechanism of this protection is
unknown, we propose three scenarios: imbalance in
Th1/Th17 cell ratio, low anti-CII antibody formation,
and CD4+ Treg cell hyperfunction.
Does imbalance in the Th17/Th1 cell ratio play a patho-
genic role in experimentally induced CIA in RORγt Tg
mice? Previous studies reported that Th1 cells have anti-
inflammatory properties in experimental arthritis [16,23,24].
Accordingly, we focused in this study on cytokine produc-
tion and transcription factor expression in CII reactive



























































































































Figure 6 RORγt enhances chemotaxis of Foxp3+ Treg cells into inflamed tissues. (A) CCR6 expression in CD4+ T cells of C57BL/6 mice and RORγt
Tg mice. (B) CCR6 expression in Foxp3+ CD4+ Treg cells and Foxp3− CD4+ non-Treg cells from of C57BL/6 mice (open bars) and RORγt Tg mice
(closed bars). (C) CD4+ cells were isolated by magnetic-activated cell sorting (MACS) from draining lymph-node (LN) cells of C57BL/6 mice (open
bars) and RORγt Tg mice (closed bars), and added to the upper well of a Transwell system. The migration assay was performed in the presence of
the indicated concentrations of CCL20 added to the bottom well. Data are numbers of respective cells that migrated to the bottom well counted
by FACS. (D) CD4+ cells of RORγt Tg mice were subjected to intracellular Foxp3 staining, and then subjected to the migration analysis as in C.
(C, D) Data are mean ± standard error of the mean. **P < 0.01, versus C57BL/6 mice, Student’s t-test. (E) Collagen-induced arthritis was induced in
C57BL/6-Foxp3GFP and RORγt Tg-Foxp3GFP mice, and CD3+CD4+ T cells that infiltrated the ankle joints were harvested at day 30 post first type II
collagen (CII) immunization and analyzed for green fluorescent protein (GFP) and CCR6 expression. Representative data of two independent
experiments with similar results. MFI, mean fluorescence intensity.
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of RORγt Tg mice, but no differences in IFNγ production
and T-bet expression, compared with C57BL/6 mice.
These findings argue against the Th17/Th1 cell imbalance
theory as an explanation for the suppression of CIA in
RORγt Tg mice.Is anti-CII antibody titer important in the develop-
ment of CIA in RORγt Tg mice? A previous study
showed that the development of CIA correlates well with
the level of serum anti-CII antibody, particularly the
IgG2 subclass [20]. The significantly low level of serum
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Figure 7 Neutralization of IL-10 exacerbates collagen-induced arthritis in RORγt Tg mice. (A) C57BL/6 mice (n = 5) and RORγt Tg mice (n =4) were
immunized intradermally with chicken type II collagen (CII) emulsified with complete Freund’s adjuvant (CFA) on days 0 and 21. Anti-IL-10 monoclonal
antibody (mAb) or isotype control antibody (ctrl Ab) were administrated intraperitoneally every 2 days from day 22 to 30 post first CII immunization.
Severity of arthritis was shown. Representative data are mean ± standard error of the mean (SEM) values. *P <0.05 versus C57BL/6 mice with the
administration of isotype ctrl Ab, #P <0.05 versus RORγt Tg mice with the administration of isotype ctrl Ab, Student’s t-test. (B) At day 10 post first CII
immunization, CD4+ cells were isolated by magnetic-activated cell sorting (MACS) from draining lymph-node cells of C57BL/6 mice (open bars) and
RORγt Tg mice (closed bars), and added to the upper well of a Transwell system. The migration assay was performed in the presence of CCL20 and
anti-IL-10 mAb or isotype ctrl Ab added to the bottom well. Data are number of respective cells that migrated to the bottom well counted by FACS.
Representative data of two independent experiments with similar results and are mean ± SEM value.
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was no significant difference in CII-specific IgG2 sub-
class between the two types of mice. Leavenworth et al.
[25] reported recently that Tfh-dependent autoantibody
production results in immune complex formation in
joint tissues, and complement activation, and that en-
hanced intra-articular inflammatory responses induced
by Th17 cells play a role in the development of auto-
immune arthritis. Tfh cells are known to express
CXCR5, ICOS, and PD-1 as superficial markers, and to
produce IL-21 for help for B cells [26-28]. In addition,
lineage commitment of Tfh cells is directly regulated by
transcription factor Bcl-6 [28]. Our results showed
lower expression levels of Bcl-6 and IL-21 in CXCR5
+CD4+ Tfh cells in RORγt Tg mice than C57BL/6 mice,
although the ICOS+PD-1+ Tfh cells increased in drain-
ing LNs of RORγt Tg mice, suggesting that the diffe-
rentiation and the function of Tfh cells might be
suppressed in RORγt Tg mice, and which is associated
with the reduced anti-CII antibody formation and the
suppression of the development of CIA. Although the
precise mechanism was not elucidated, the low level of
anti-CII antibody might be also related to the dimin-
ished ectopic lymphoid follicle formation induced by
local synovial inflammation, which is distinct feature of
autoimmune arthritis [29,30].
The third possible etiology of arthritis in RORγt Tg
mice involves overexpression of RORγt. This scenario is
based on the attenuation of CIA in not only RORγt Tgmice but also in C57BL/6 mice with adoptive transfer of
CD4+ T cells from RORγt Tg mice. Forkhead family tran-
scription factor Foxp3 is characteristically expressed in a
major subset of regulatory T cells [31]. Foxp3+ Treg cells
can suppress the activation of Th17 cells and other effector
T cell subsets as well as the development of certain auto-
immune diseases, including CIA [32]. Interestingly, RORγt
expression on Foxp3+ Tregs was significantly upregulated
in RORγt Tg mice compared with C57BL/6 mice, although
there were no difference between the two groups of mice
in Foxp3 expression on CD4+ T cells. Foxp3+ Treg cells
also expressed high levels of the co-inhibitory molecule,
GITR [33], produced high amounts of IL-10 but not IL-17,
and suppressed the proliferation of effector T cells in
RORγt Tg mice. Moreover, the suppression of CIA was
partially cancelled by the neutralization of IL-10 in RORγt
Tg mice, suggesting that IL-10 produced from Foxp3+ Treg
cells might be related to attenuation of CIA in RORγt Tg
mice. In addition to our observations, Lochner et al. re-
ported that RORγt+ T cells include pro-inflammatory IL-
17-producing Th17 cells and IL-10-producing Foxp3+ Treg
cells, and that equilibrium of two types of RORγt+ cells are
tightly controlled in vivo [34]. Although the precise mech-
anism of enhanced suppressive capacity of Foxp3+ Treg
cells in RORγt Tg mice was not elucidated, these data sup-
port our hypotheses that IL-10-producing RORγt+Foxp3+
Treg cells suppress the development of CIA.
Previous studies report that RORγt can induce the ex-
pression of CCR6, which is also known to play a role in
Kondo et al. Arthritis Research & Therapy  (2015) 17:105 Page 13 of 14arthritogenic Th17 cell recruitment to inflamed joints
[14]. Furthermore, CCR6-expressing Treg cells can reduce
the Th17-mediated inflammatory response [35,36]. In the
present study, RORγt upregulation induced overexpres-
sion of CCR6 in Foxp3+ Treg cells, which in turn resulted
in preferential migration of Foxp3+ Treg cells in response
to CCL20, a ligand of CCR6. Although we have no direct
evidence for the involvement of Foxp3+ Treg in the patho-
genesis of CIA, the results of previous studies and our
findings suggest upregulation of RORγt enhances the ex-
pression of CCR6 on Foxp3+ Treg cells, resulting in pref-
erential infiltration of Foxp3+ Treg cells into inflamed
joints and suppression of autoimmune synovitis.Conclusion
Our results suggest that the protective effects of RORγt
overexpression against the development of CIA in mice
were mediated through the anti-inflammatory effects of
intra-articular IL-10-producing CCR6+RORγt+Foxp3+ Treg
cells. The results also suggest that modulation of transcrip-
tion factor expression on CD4+ T cells is a potentially use-
ful therapeutic approach in RA.
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